We are live on
!
Find out more
GP
Girard Partners Portfolio holdings
AUM
$1.06B
1-Year Est. Return
17.26%
This Fund
S&P 500
This Quarter
Est. Return
+2.76%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$462M
AUM Growth
+$48M
(+12%)
Cap. Flow
+$37.7M
Cap. Flow
% of AUM
8.17%
Top 10 Holdings %
Top 10 Hldgs %
22.16%
Holding
273
New
44
Increased
150
Reduced
60
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.53M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.4M |
| 3 |
Edison International
EIX
|
+$1.37M |
| 4 |
Merck
MRK
|
+$1.37M |
| 5 |
Vanguard Total International Bond ETF
BNDX
|
+$1.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.09M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$919K |
| 3 |
Coca-Cola
KO
|
+$666K |
| 4 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$515K |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$485K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.49% |
| 2 | Financials | 11.84% |
| 3 | Technology | 10.69% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Staples | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.89T
| $21.9M | 4.74% |
607,708
+1,988
| +0.3% | +$73.5K |
|
2
Johnson & Johnson
JNJ
$602B
| $10.9M | 2.35% |
82,224
+8,200
| +11% | +$1.05M |
|
|
3
iShares Core US Aggregate Bond ETF
AGG
$139B
| $9.46M | 2.05% |
86,389
+12,824
| +17% | +$1.4M |
|
4
Blackrock
BLK
$168B
| $9.38M | 2.03% |
22,212
+1,182
| +6% | +$471K |
|
5
Altria Group
MO
$122B
| $8.96M | 1.94% |
120,297
+7,513
| +7% | +$550K |
|
6
Visa
V
$694B
| $8.82M | 1.91% |
94,049
+5,471
| +6% | +$508K |
|
7
Microsoft
MSFT
$2.98T
| $8.51M | 1.84% |
123,505
+8,871
| +8% | +$609K |
|
8
Walt Disney
DIS
$173B
| $8.47M | 1.83% |
79,768
+6,439
| +9% | +$705K |
|
9
Home Depot
HD
$347B
| $8.13M | 1.76% |
53,033
+4,168
| +9% | +$639K |
|
10
ExxonMobil
XOM
$605B
| $7.86M | 1.7% |
97,297
+9,551
| +11% | +$781K |
|
11
Amgen
AMGN
$201B
| $6.91M | 1.5% |
40,144
+5,792
| +17% | +$942K |
|
12
Intel
INTC
$487B
| $6.79M | 1.47% |
201,334
+20,030
| +11% | +$717K |
|
|
13
Merck
MRK
$315B
| $6.72M | 1.46% |
109,975
+22,426
| +26% | +$1.37M |
|
14
Vanguard Small-Cap Value ETF
VBR
$37.1B
| $6.66M | 1.44% |
54,151
+1,453
| +3% | +$178K |
|
15
Vanguard Value ETF
VTV
$186B
| $6.44M | 1.39% |
66,710
+8,123
| +14% | +$777K |
|
16
UnitedHealth
UNH
$384B
| $6.33M | 1.37% |
34,161
+2,199
| +7% | +$386K |
|
17
Union Pacific
UNP
$178B
| $6.28M | 1.36% |
57,656
+2,975
| +5% | +$324K |
|
18
Vanguard Growth ETF
VUG
$221B
| $6.06M | 1.31% |
286,350
+11,424
| +4% | +$239K |
|
|
19
JPMorgan Chase
JPM
$912B
| $5.79M | 1.25% |
63,294
+17,750
| +39% | +$1.53M |
|
20
Travelers Companies
TRV
$71.8B
| $5.61M | 1.21% |
44,330
+1,161
| +3% | +$143K |
|
21
Verizon
VZ
$183B
| $5.58M | 1.21% |
124,924
+9,546
| +8% | +$445K |
|
22
Cisco
CSCO
$432B
| $5.47M | 1.18% |
174,786
+14,422
| +9% | +$470K |
|
23
AT&T
T
$153B
| $5.37M | 1.16% |
188,457
+22,993
| +14% | +$678K |
|
24
CVS Health
CVS
$136B
| $5.22M | 1.13% |
64,915
+4,893
| +8% | +$386K |
|
25
VF Corp
VFC
$6.86B
| $5.16M | 1.12% |
95,184
+7,774
| +9% | +$401K |
|
Similar funds
PO
PRIG
KI
H
RVPG
AC
AT
IFAM
Girard Partners's Q2 2017 Portfolio in Review
As of Q2 2017, Girard Partners held 273 positions worth $462M, up 12% from $414M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Girard Partners deployed $37.7M of net new capital in Q2 2017, opening 44 new positions and adding to 150 existing holdings. Its largest new stake was Edison International: 17,087 shares worth $1.34M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $1.09M trimmed.
- Girard Partners's largest Q2 2017 buy was Edison International: 17,087 shares worth $1.34M.
- Girard Partners added most to JPMorgan Chase in Q2 2017, an estimated $1.53M increase.
- Girard Partners's biggest Q2 2017 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.09M.
- Girard Partners fully exited Vanguard Short-Term Bond ETF in Q2 2017, selling an estimated $485K.
- Girard Partners's ten largest holdings make up 22% of its $462M portfolio in Q2 2017.
- Girard Partners opened 44 new positions and closed 8 in Q2 2017.
- Girard Partners's portfolio value rose 12% quarter-over-quarter to $462M.
Based on Girard Partners's 13F filing for Q2 2017, filed 8 Aug 2017.